false 1 Cannabis: Medical Treatments Tonia Antoniazzi What progress the Government has made on making medical cannabis available to people who need it. Gower 911421 17 Department of Health and Social Care House of Commons 2019-06-18T16:50:49.883Z West Suffolk Matt Hancock false 2019-06-18 Biography information for Matt Hancock <p>The Government acted swiftly to change the law and those patients for whom it is clinically appropriate can be prescribed medicinal cannabis. It is a clinical decision whether to prescribe, and prescriptions of medicinal cannabis are available, and being issued where it is judged clinically appropriate for the patient.</p><p /><p /> Biography information for Tonia Antoniazzi Health and Social Care 2019-06-18 Health and Social Care Department of Health and Social Care 264317 1 Anxiety: Young People 2019-06-18T16:41:44.47Z Thurrock Jackie Doyle-Price false 2019-06-18 Biography information for Dame Jackie Doyle-Price <p>Through the Department of Education, we know that the Higher Education Statistics Agency reported that, in 2017/18, 24,815 UK resident entrants to higher education settings disclosed a diagnosed mental health condition such as anxiety. Robust data is not available to determine how much of this increase is down to increased disclosure resulting from reduced stigma, and how much is due to increased prevalence.</p><p>Any disclosure of diagnosed mental health conditions by higher education students to their institution is voluntary. The actual number of university students with diagnosed mental health conditions is therefore unknown.</p> To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of young people (a) attending and (b) not attending university who suffer from anxiety. Health and Social Care Coventry South false Mr Jim Cunningham Health and Social Care 2019-06-13 Biography information for Mr Jim Cunningham 17 Health and Social Care 2019-06-13 To ask the Secretary of State for Health and Social Care, what recent assessment he has made of trends in the rate of suicide among men in Wolverhampton; and what steps he is taking to improve mental health services in the West Midlands. 2019-06-18T16:42:26.05Z Thurrock Jackie Doyle-Price false 2019-06-18 <p>The latest update on suicide prevention from the health scrutiny panel at City of Wolverhampton Council (June 2019), shows that 66 deaths were registered as suicides for the period of 2015-17 and 54 of these (82%) were male.</p><p> </p><p>In ‘Making Wolverhampton a Suicide Safer Community: Wolverhampton Suicide Prevention Strategy 2016–2020’, City of Wolverhampton Council has set the following aims to reduce suicides:</p><p> </p><p>- provide a multi-agency approach to suicide prevention across Wolverhampton;</p><p>- raise awareness of suicide, compelling organisations and the community to take positive action;</p><p>- upskill workforces through information and knowledge enabling them to better understand and respond to poor mental wellbeing and suicide ideation;</p><p>- influence services and policies so that suicide prevention is robustly considered and embedded in routine business; and</p><p>- provide a coordinated suicide support offer which can be accessed by services and communities.</p><p> </p> 17 Biography information for Emma Reynolds Health and Social Care Wolverhampton North East Suicide: Wolverhampton Emma Reynolds 1 false 264388 Department of Health and Social Care 263694 General Practitioners: Leicester Keith Vaz Health and Social Care Leicester East 2019-06-19T14:27:53.127Z South Ribble Seema Kennedy false 2019-06-19 Biography information for Seema Kennedy <p>Leicester City Clinical Commissioning Group (CCG) is in the process of finalising the structure for the Primary Care Networks (PCNs) in Leicester with general practitioner practices. PCNs are agreed for the majority of practices in the area. It is expected that confirmation for the remaining small number of practices not yet signed up will be given before the deadline of 30 June. As soon as the full structure is agreed, it will be communicated with the Leicester population and stakeholders. The CCG’s expectation is that all practices will be part of a PCN.</p><p><strong> </strong></p> Health and Social Care 17 2019-06-12 1 Biography information for Keith Vaz To ask the Secretary of State for Health and Social Care, how many GP practices in Leicester have joined the NHS Primary Care Network. true Department of Health and Social Care Department of Health and Social Care 2019-06-12 Health and Social Care 263683 To ask the Secretary of State for Health and Social Care, what steps he is taking to improve NHS waiting times for cancer patients. Birmingham, Selly Oak Health and Social Care 1 Cancer: Health Services 2019-06-19T14:26:47.083Z South Ribble Seema Kennedy false 2019-06-19 <p>The NHS Long Term Plan sets out plans to improve early cancer diagnosis, and a new ambition that, by 2028, the proportion of cancers diagnosed at stages one and two will rise from around half to three-quarters of cancer patients. This will be achieved through raising greater awareness of symptoms of cancer, accelerating access to diagnosis and treatment, maximising the number of cancers that are identified through screening, and harnessing new innovations in technology. A radical overhaul of the way diagnostic services are delivered will ensure that people can get their diagnosis more quickly, including the roll-out of new Rapid Diagnostic Centres across the country to upgrade and bring together the latest diagnostic equipment and expertise.</p><p> </p><p>The independent cancer taskforce recommended the introduction of a new faster diagnosis standard to ensure that people receive a life changing confirmation of whether or not they have cancer within 28 days. This proposed new standard is being considered as part of the clinical review of National Health Service access standards currently being undertaken by NHS England.</p> false 17 Biography information for Steve McCabe Steve McCabe Biography information for Stephen Morgan 2019-06-19T14:20:00.42Z South Ribble Seema Kennedy false 2019-06-19 <p>The United Kingdom participates in various transparency initiatives, including the European Integrated Price Information Database, the World Health Organization’s Pharmaceutical Pricing Reimbursement Information Network, and the Global Fund Price and Quality Database. The UK has a long-established and globally-recognised track record of assessing the price of new, innovative medicines according to their clinical value, rather than pricing by their development costs or international reference prices.</p><p>We believe that is the right approach: ensuring the development of the best medicines in areas of high unmet need are rewarded. The Government could not, therefore, agree to a resolution which had the potential to increase medicines prices and reduce patient access, by reducing the ability of the National Health Service to undertake commercial negotiations with pharmaceutical companies on the price of new medicines.</p><p>The approach taken by the NHS has meant we were the first country in Europe to offer innovative CAR-T therapies, alongside many other new medicines.</p><p> </p><p> </p><p> </p> 263223 1 Medical Treatments Health and Social Care Stephen Morgan false Department of Health and Social Care 2019-06-11 Health and Social Care To ask the Secretary of State for Health and Social Care, what assessment he has made of the UK Government’s response to the resolution on improving the transparency of markets at the 72nd World Health Assembly in Geneva on the ability of people in the UK to access medicines. 17 Portsmouth South Health and Social Care Department of Health and Social Care James Frith NHS: Drugs Health and Social Care 2019-06-19T14:22:30.34Z South Ribble Seema Kennedy false 2019-06-19 <p>The vast majority of medicines are not subject to supply problems and every day over 2 million prescription items are successfully dispensed in England.</p><p>Where problems do occur the Department’s Medicines Supply Team has well established procedures to deal with medicine shortages and works closely with all stakeholders to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p>We are aware of ongoing supply issues with the Adalat range of the drug nifedipine due to manufacturing capacity constraints. We have been working closely with all suppliers of generic and other brands of nifedipine to maintain overall supply of this medicine to patients and have provided regular updates about the situation to the National Health Service.</p><p>We will continue to work closely with all manufacturers of nifedipine preparations to monitor the overall supply situation to ensure supplies continue to remain available.</p> Bury North 1 To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle shortages of (a) Adalat, (b) Nifedipine and (c) other common medicines. Biography information for James Frith 17 263235 false 2019-06-11 Health and Social Care Department of Health and Social Care North Antrim false To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle obesity. Obesity Health and Social Care 263150 2019-06-11 17 Biography information for Ian Paisley Ian Paisley 2019-06-19T14:17:06.49Z South Ribble Seema Kennedy false 2019-06-19 <p>I refer the hon. Member to the answer given by the former Parliamentary Under-Secretary of State for Public Health and Primary Care (Steve Brine MP) to the hon. Member for Cardiff Central (Jo Stevens MP) on 28 February 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-02-25/225540/" target="_blank">225540</a>.</p><p> </p><p> </p> 1 17 1 Biography information for Ian Blackford To ask the Secretary of State for Health and Social Care, how many companies are licensed to sell cannabis products to the NHS. Department of Health and Social Care 2019-06-19T09:39:54.803Z South Ribble Seema Kennedy false 2019-06-19 <p>Any company meeting the standards for the manufacture of unlicensed medicinal products, can supply cannabis-based products for medicinal use.</p><p> </p><p>Cannabis-based products for medicinal use are Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001, which means that manufacturers, importers and distributors of these products must hold valid Home Office and Medicines and Healthcare products Regulatory Agency (MHRA) licences for the relevant activities which will include possession, supply and production of controlled drugs. Where products are sourced from abroad, importers must obtain an import licence from the Home Office and non-objection to import from the MHRA for each individual import of a controlled drug.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> Ross, Skye and Lochaber false Health and Social Care Ian Blackford Cannabis: Medical Treatments Health and Social Care 263171 2019-06-11 To ask the Secretary of State for Health and Social Care, what progress he has made on ensuring that medical cannabis is available to people who need it. Frank Field Biography information for Lord Field of Birkenhead Department of Health and Social Care 263063 2019-06-11 Health and Social Care false Birkenhead 1 Health and Social Care Cannabis: Medical Treatments 2019-06-19T14:21:18.483Z South Ribble Seema Kennedy false 2019-06-19 <p>The law was changed on 1 November 2018 to allow clinicians on the General Medical Council’s ‘Specialist Register’ to prescribe cannabis-based products for medicinal use, where clinically appropriate and in the best interest of patients.</p><p>Interim clinical guidance has been issued by the Royal College of Physicians, the British Paediatric Neurology Association and the Association of British Neurologists to support doctors looking to prescribe cannabis-based products. The National Institute for Health and Care Excellence (NICE) has been commissioned to develop updated clinical guidance on the prescribing of cannabis-based medicinal products, which will be published by October 2019. It will be based on the best available international evidence and will have been produced using NICE’s world-renowned process for delivering such guidance.</p> 17 16 0 10 1